Search clinical trials for: chemotherapy side effects

Total 164374 results

Tanta University

Recruiting

Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer (HFS)

Colorectal Cancer | Hand and Foot Syndrome | Erythrodysesthesia Syndrome | HFS

Egypt
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Embryonal Rhabdomyosarcoma | Fusion-Negative Alveolar Rhabdomyosarcoma | Spindle Cell/Sclerosing Rhabdomyosarcoma

United States, Australia, Canada, New Zealand
Centre Georges Francois Leclerc

Recruiting

Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration (EMEG-ECDD)

Localized Breast Cancer

France
University of Virginia

Recruiting

Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer (Breast53)

Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III

United States
Vanderbilt University Medical Center
University of Utah

Recruiting

nCCR for Chemotherapy Related Cognitive Impairment Randomized Study

Chemotherapy-Related Cognitive Impairment | Chemo-brain

United States
NHS Greater Glasgow and Clyde

Recruiting

Biomarkers for Chemotherapy Associated Neurotoxicity (BioCAN)

Chemotherapy-Related Cognitive Impairment

United Kingdom
Affiliated Hospital of Qinghai University

Recruiting

Personalized Electroacupuncture Treatment for Chemotherapy-induced Nausea and Vomiting in Breast Cancer (PET)

Cancer

China
Maria Sklodowska-Curie National Research Institute...
Medical Research Agency, Poland

Recruiting

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines (EMPACT)

Cardiotoxicity

Poland
Georgetown University

Recruiting

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer (RAGE)

Non-metastatic Breast Cancer | Cancer Related Cognitive Decline

United States
Shengjing Hospital

Not yet recruiting

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Breast Neoplasms
University of Nove de Julho

Not yet recruiting

Effects of Continuous and Interval Physical Training Through the Intensity of the Incremental Shuttle Walk Test, on Functional Capacity and Quality of Life in Women With Malignant Breast Cancer During Chemotherapy Treatment

Exercise Addiction | Breast Cancer Female
Sun Yat-sen University

Recruiting

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Breast Cancer | Chemotherapy-Related Cognitive Impairment

China
Necmettin Erbakan University

Not yet recruiting

Effects of Ketogenic Diet in Overweight and Obese Women With Breast Cancer

Breast Cancer Female
The Hong Kong Polytechnic University
Ruijin Hospital

Recruiting

The Effects of a Nurse-led mHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy (mChemo)

Breast Cancer | Chemotherapeutic Toxicity

China
University College, London
British Heart Foundation

Recruiting

Defining Robust Predictors of Chemotherapy Related Cardiotoxicity

Gastrointestinal Neoplasms | Cardiotoxicity

United Kingdom
Rapa Therapeutics LLC

Recruiting

RAPA-201 Therapy of Solid Tumors

Breast Cancer | Head and Neck Cancer | Gastric Cancer | Solid Tumor | Bladder Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Malignant Melanoma | Carcinoma of Unknown Primary | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of Oral Cavity | Squamous Cell Carcinoma of Nasopharynx and other conditions

United States
Xijing Hospital

Not yet recruiting

RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer

Breast Cancer | HER2-positive Breast Cancer
Sunnybrook Health Sciences Centre

Recruiting

Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy

Ototoxic Hearing Loss

Canada
Sun Yat-sen University

Recruiting

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Breast Cancer

China
Abramson Cancer Center at Penn Medicine
American Heart Association

Recruiting

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer (PCT)

Cardiovascular Diseases | Prostate Cancer | Drug-Related Side Effects and Adverse Reactions | Cardiotoxicity

United States
Aiping Shi

Recruiting

Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC)

China
Abramson Cancer Center at Penn Medicine
American Heart Association

Recruiting

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer (CCT2)

Cardiovascular Diseases | Breast Cancer | Drug-Related Side Effects and Adverse Reactions | Cardiotoxicity

United States
Fudan University

Recruiting

Reverse Triple Negative Immune Resistant Breast Cancer (Renaissance)

Triple-negative Breast Cancer

China
Dana-Farber Cancer Institute
Gilead Sciences; AstraZeneca; Eisai Inc.; Paxman Coolers Limited; Daiichi Sankyo

Recruiting

Scalp Cooling in MBC

Metastatic Breast Cancer | Chemotherapy-induced Alopecia

United States
St Vincent's Hospital, Sydney

Recruiting

Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer (4CAST)

Triple Negative Breast Cancer

Australia
Assiut University

Not yet recruiting

Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer

Metastasis Breast
Sun Yat-sen University

Recruiting

Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer (Increase)

Breast Cancer

China
Hospital Sírio-Libanês
Ministry of Health, Brazil

Recruiting

Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy (CardioTox)

Cancer

Brazil
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Recruiting

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma and other conditions

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG (DETECT)

Lymphoma, Non-Hodgkin | Lymphoma, Hodgkin

France
Guangdong Provincial People's Hospital

Recruiting

The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC (NeoSACT)

Triple Negative Breast Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: A Phase II Trial

Breast Cancer | Hormone-receptor Positive Breast Cancer

China
Hoffmann-La Roche

Recruiting

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy (Astefania)

Breast Cancer

Korea, Republic of, United States, Australia, China, Ukraine, Spain, United Kingdom, Turkey, Mexico, Brazil, Belgium, Denmark, Germany, Greece, Portugal, Russian Federation, Taiwan, France, Kenya, Thailand, Romania, Italy, Czechia, Hu... and more
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline; National Institute for Health Research, United Kingdom; Kidney... and other collaborators

Recruiting

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V (PROTECT-V)

Covid19

United Kingdom
Peking University People's Hospital

Recruiting

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients

HER2-negative Early Breast Cancer

China
University Medicine Greifswald
University of Greifswald

Recruiting

Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment (NeuroMod-PCCI)

Breast Cancer | Cognitive Impairment

Germany
National Cancer Institute (NCI)

Recruiting

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

Lymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditions

United States
Istituto Ortopedico Rizzoli

Recruiting

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse (Metform-Bone)

Osteosarcoma | Ewing Sarcoma

Italy
Peking Union Medical College

Not yet recruiting

Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway

Breast Cancer

China
Sun Yat-sen University

Recruiting

Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Jens Rikardt Andersen

Recruiting

Lean Body Mass and Side Effects in Patients With Lymphoma

Malignant Lymphoma

Denmark
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer

Breast Cancer

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Recruiting

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Vitamin D Deficiency | Triple Negative Breast Cancer | Invasive Breast Cancer

United States
Shandong Cancer Hospital and Institute
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer

China
Persephone Biosciences

Recruiting

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Colorectal Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Pancreas Cancer

United States
University of Pittsburgh
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Telehealth and Memory Study (TAMS)

Chemotherapy-related Cognitive Dysfunction

United States
Second Affiliated Hospital, School of Medicine,...
Women's Hospital School Of Medicine Zhejiang University; Zhejiang Provincial... and other collaborators

Recruiting

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

HER2-negative Breast Cancer | Neoadjuvant Chemotherapy

China
University of Sao Paulo General Hospital
Hospital Israelita Albert Einstein; Universidade Federal Fluminense

Recruiting

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Cardiovascular Disease | Breast Cancer | Cardiotoxicity | Neurovascular Disorder | Endothelial Disfunction

Brazil
Seoul National University Hospital

Recruiting

Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.

Retinoblastoma

Korea, Republic of
Montreal Heart Institute
AstraZeneca

Recruiting

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia (CarChem)

Lymphoma | Leukemia | Breast Cancer

Canada

Search clinical trials for: chemotherapy side effects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations